Feasibility and efficacy of administration of bortezomib-containing regimens to patients over the age of 70 years

Br J Haematol. 2011 Apr;153(2):273-5. doi: 10.1111/j.1365-2141.2010.08565.x. Epub 2011 Jan 31.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Boronic Acids / administration & dosage*
  • Boronic Acids / adverse effects
  • Bortezomib
  • Cohort Studies
  • Female
  • Health Services for the Aged
  • Humans
  • Male
  • Multiple Myeloma / therapy*
  • Pyrazines / administration & dosage*
  • Pyrazines / adverse effects

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib